A detailed history of Hennion & Walsh Asset Management, Inc. transactions in Stryker Corp stock. As of the latest transaction made, Hennion & Walsh Asset Management, Inc. holds 9,116 shares of SYK stock, worth $3.51 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
9,116
Previous 5,669 60.8%
Holding current value
$3.51 Million
Previous $1.93 Million 70.75%
% of portfolio
0.16%
Previous 0.1%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

BUY
$315.94 - $371.96 $1.09 Million - $1.28 Million
3,447 Added 60.8%
9,116 $3.29 Million
Q2 2024

Jul 19, 2024

BUY
$324.3 - $354.67 $244,522 - $267,421
754 Added 15.34%
5,669 $1.93 Million
Q1 2024

Apr 17, 2024

BUY
$293.94 - $358.71 $617,861 - $754,008
2,102 Added 74.72%
4,915 $1.76 Million
Q4 2023

Jan 10, 2024

BUY
$253.85 - $299.46 $185,818 - $219,204
732 Added 35.18%
2,813 $842,000
Q3 2023

Oct 27, 2023

BUY
$266.54 - $302.43 $554,669 - $629,356
2,081 New
2,081 $568,000
Q3 2022

Nov 14, 2022

SELL
$189.27 - $231.83 $730,582 - $894,863
-3,860 Reduced 61.62%
2,404 $487,000
Q2 2022

Jul 19, 2022

SELL
$194.09 - $276.37 $703,964 - $1 Million
-3,627 Reduced 36.67%
6,264 $1.25 Million
Q1 2022

Apr 26, 2022

SELL
$245.33 - $277.77 $1.79 Million - $2.02 Million
-7,283 Reduced 42.41%
9,891 $2.64 Million
Q4 2021

Feb 14, 2022

SELL
$236.63 - $276.44 $471,366 - $550,668
-1,992 Reduced 10.39%
17,174 $4.59 Million
Q3 2021

Nov 12, 2021

SELL
$248.9 - $280.09 $58,491 - $65,821
-235 Reduced 1.21%
19,166 $5.05 Million
Q2 2021

Aug 13, 2021

BUY
$242.95 - $267.0 $579,921 - $637,329
2,387 Added 14.03%
19,401 $5.04 Million
Q1 2021

May 17, 2021

BUY
$221.01 - $248.82 $3.76 Million - $4.23 Million
17,014 New
17,014 $4.14 Million

Others Institutions Holding SYK

About STRYKER CORP


  • Ticker SYK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 378,320,992
  • Market Cap $146B
  • Description
  • Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products c...
More about SYK
Track This Portfolio

Track Hennion & Walsh Asset Management, Inc. Portfolio

Follow Hennion & Walsh Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hennion & Walsh Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hennion & Walsh Asset Management, Inc. with notifications on news.